Lead Kicked From Pharma Investor Case Over Rogue Emails

The lead plaintiff in a securities class action against Spectrum Pharmaceuticals in Manhattan federal court was removed from the case Tuesday when a federal judge found he broke confidentiality rules by...

Already a subscriber? Click here to view full article